SCHEMBL23966148

SCHEMBL23966148

CCn1c(NC(=O)c2cnc(N)nc2)nc2c(OC)c(OCCCC(N)=O)ccc2c1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CB P42338 7/20 0.41
PIK3CD O00329 3/20 0.41
PIK3CA P42336 3/20 0.41
PIK3CG P48736 3/20 0.41
CHRM2 P08172 1/20 0.41
PIK3R1 P27986 1/20 0.41
MTOR P42345 1/20 0.41
RAB27A P51159 1/20 0.41
KMT2A Q03164 1/20 0.35
ADORA2A P29274 1/20 0.34
HDAC1 Q13547 1/20 0.34
HDAC8 Q9BY41 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34
MAPT P10636 3/20 0.34
STING1 Q86WV6 1/20 0.34
PDE4A P27815 1/20 0.33
PDE4B Q07343 1/20 0.33
PDE4C Q08493 1/20 0.33
PDE4D Q08499 1/20 0.33
PIK3C2A O00443 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23965967 0.97 PIK3CB (0.39) PIK3CBPIK3CDPIK3CAPIK3CGCHRM2
SCHEMBL22183738 0.91 PIK3CB (0.37) PIK3CBPIK3CDPIK3CAPIK3CGCHRM2
SCHEMBL23966116 0.90 PIK3CB (0.39) PIK3CBPIK3CDPIK3CAPIK3CGCHRM2
SCHEMBL24211105 0.90 PIK3CB (0.43) PIK3CBPIK3CDPIK3CAPIK3CGCHRM2
SCHEMBL24211069 0.89 PIK3CB (0.39) PIK3CBPIK3CDPIK3CAPIK3CGCHRM2
SCHEMBL23966059 0.89 PIK3CB (0.39) PIK3CBPIK3CDPIK3CAPIK3CGCHRM2
SCHEMBL23965961 0.89 PIK3CB (0.39) PIK3CBPIK3CDPIK3CAPIK3CGCHRM2
SCHEMBL24211092 0.89 PIK3CB (0.39) PIK3CBPIK3CDPIK3CAPIK3CGCHRM2
SCHEMBL23966065 0.88 PIK3CB (0.38) PIK3CBPIK3CDPIK3CAPIK3CGCHRM2
SCHEMBL22183816 0.88 PIK3CB (0.38) PIK3CBPIK3CDPIK3CAPIK3CGCHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220017505-A1 AMINOQUINAZOLINONE AND AMINOISOQUINOLINONE DERIVATIVES AND APPLICATION THEREOF SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) 2022-01-20 US disclosed
EP-3904343-A1 AMINO QUINAZOLINONE, AMINO ISOQUINOLONE DERIVATIVES AND APPLICATION THEREOF Zhejiang University (CN) 2021-11-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220017505-A1 AMINOQUINAZOLINONE AND AMINOISOQUINOLINONE DERIVATIVES AND APPLICATION THEREOF PIK3R5, PIK3CA, PIK3R1 PIK3CB 9/4885PIK3CD 4/4885PIK3CA 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.